Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2025-02-12

FDA Approved: EZALLOR SPRINKLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for EZALLOR SPRINKLE (rosuvastatin) to support the sprinkle dosage-form labeling. This action expands the product's appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZALLOR SPRINKLE (ROSUVASTATIN)

Snippet

SUPPL AP for EZALLOR SPRINKLE (ROSUVASTATIN)